Skip to content
Open access · CC-BY via OpenAlex

Metformin: A stroke of luck

Mohamad Aljofan, Abduzhappar Gaipov

Electronic Journal of General Medicine · 2019 · ▲ 9 citations

Abstract

Metformin is an oral glucose-lowering drug that has been widely used for more than half a century. Both the American Diabetes Association and the European Association for the study of Diabetes recommend metformin as the first line therapy for the treatment of type II diabetes mellitus. Metformin has considerably evolved from being an antidiabetic into a drug with a wider potential of therapeutic uses such as anticancer, antiaging, treatment of gestational hypertension, preeclampsia and weight loss. In addition to the in-label use of metformin as an anti-hyperglycemic medication, it is widely prescribed as an off label therapy for young women with Poly Cystic Ovary Syndrome for the treatment of symptoms associated with the disorder. This article is a brief summary that lists and briefly discusses current and potential non-hyperglycemic uses and effects of metformin.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.29333/ejgm/108679
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Aljofan, M., &amp; Gaipov, A. (2019). Metformin: A stroke of luck. <em>Electronic Journal of General Medicine</em>. https://doi.org/10.29333/ejgm/108679
Vancouver
Aljofan M, Gaipov A. Metformin: A stroke of luck. Electronic Journal of General Medicine. 2019. doi:10.29333/ejgm/108679.
BibTeX
@article{mohamad2019Metfor, title = {Metformin: A stroke of luck}, author = {Mohamad Aljofan and Abduzhappar Gaipov}, journal = {Electronic Journal of General Medicine}, year = {2019}, doi = {10.29333/ejgm/108679}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings